Sun Pharma Advanced Research Company Share Price
Small Cap | Pharmaceuticals and health care | NSE: SPARC | BSE: 532872
₹145.54 
-4.46 (-2.97 %)
Last Updated: 04 Apr 2025 03:59 PM
BULLISH
Overview
Open (₹) 150.00
High (₹) 151.00
Low (₹) 139.32
Prev. Close (₹) 150.00
Volume 16,28,390
VWAP (₹) 113.44
ROCE (%) -154.06
Industry P/E 61.88
TTM P/E -12.16
P/B Ratio 37.51
Market Cap (₹) Cr.4,723.09
Dividend Yield (%)--
EPS (₹) -11.93
ROE-307.47%
Sales Growth (%) -68.36
Profit Growth (%)73.96
Day Range
151.00151.00
52 Week Range
109.20474.00
Historical Returns
Returns (6M)
-27.93 %
Returns (1Y)
-66.44 %
Returns (3Y)
-50.17 %
Returns (5Y)
25.63 %
Returns (6M)
-27.93 %
Returns (1Y)
-66.44 %
Returns (3Y)
-50.17 %
Returns (5Y)
25.63 %
SWOT Analysis
- Company with (52.56%) TTM EPS Growth
- Company with Low Debt
- Growth in Net Profit Margin (QoQ)
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
BULLISHRSI 37.97
MFI 11.27
ATR 7.21
Commodity Channel Index -145.41
ROC125 -50.22
ROC21 -28.79
Williams %R -95.86
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 119.01 | 125.62 | 129.92 | 114.71 | 108.10 | 103.80 | 97.19 |
| Week Ago | 134.36 | 139.28 | 142.26 | 131.38 | 126.46 | 123.48 | 118.56 |
| Month Ago | 166.70 | 171.35 | 175.70 | 162.35 | 157.70 | 153.35 | 148.70 |
EMA & SMA
145.54
Current Price
Bullish Moving Averages
12
Bearish Moving Averages
8
5 Day 125.21
9 Day 129.58
10 Day 131.31
12 Day 135.57
14 Day 137.68
20 Day 143.51
26 Day 148.46
50 Day 170.67
100 Day 189.77
200 Day 207.02
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 20 Mar, 2025 | ₹145.76 | 24,99,621 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 20 Mar, 2025 | ₹145.83 | 24,99,621 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 07 Mar, 2025 | ₹137.63 | 27,97,403 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 07 Mar, 2025 | ₹137.57 | 27,97,403 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 16 Dec, 2024 | ₹233.05 | 24,46,772 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 16 Dec, 2024 | ₹232.87 | 24,46,772 | NSE |
| MANSI SHARE AND STOCK ADVISORS PVT LTD | bulk | Sell | 02 May, 2024 | ₹236.80 | 19,38,447 | NSE |
| MANSI SHARE AND STOCK ADVISORS PVT LTD | bulk | Buy | 02 May, 2024 | ₹222.50 | 15,36,426 | NSE |
| MANSI SHARE AND STOCK ADVISORS PVT LTD | bulk | Sell | 25 Apr, 2024 | ₹272.43 | 15,67,203 | NSE |
| MANSI SHARE AND STOCK ADVISORS PVT LTD | bulk | Buy | 25 Apr, 2024 | ₹270.91 | 26,91,489 | NSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 24 Feb, 2023 | SUDHIR VALIA | Pledge | ₹190.80 | 18,00,000 | NSE |
| 24 Feb, 2023 | RAKSHA VALIA | Pledge | ₹190.80 | 22,00,000 | NSE |
| 12 Jan, 2023 | Dilip S. Shanghvi | Disposal | ₹ | 2,52,80,899 | NSE |
| 12 Jan, 2023 | Dilip S. Shanghvi | Acquisition | ₹133.50 | 2,52,80,899 | NSE |
| 28 Dec, 2022 | RAKSHA VALIA | Pledge | ₹213.80 | 19,00,000 | NSE |
| 05 Dec, 2022 | Raksha Valia | Pledge | ₹250.70 | 30,80,000 | NSE |
| 01 Sept, 2022 | Raksha Valia | Pledge | ₹229.40 | 10,00,000 | NSE |
| 21 Jun, 2022 | RAKSHA VALIA | Pledge | ₹174.20 | 4,30,000 | NSE |
| 20 Jun, 2022 | RAKSHA VALIA | Pledge | ₹204.40 | 8,70,000 | NSE |
| 24 May, 2022 | RAKSHA VALIA | Pledge | ₹216.85 | 13,00,000 | NSE |
Corporate Actions
No corporate actions available.
Announcements
| Date | Source | Detail |
|---|---|---|
| 31 Mar, 2025 | NSE India | Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated March 31, 2025, titled ""Press Release about submission of IND Application for SBO-154 to USFDA"". |
| 27 Mar, 2025 | NSE India | Sun Pharma Advanced Research Company Limited has informed the Exchange about Closure of Trading Window |
| 27 Mar, 2025 | NSE India | Sun Pharma Advanced Research Company Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 25 Mar, 2025 | NSE India | Significant movement in price has been observed in Sun Pharma Advanced Research Company Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Sun Pharma Advanced Research Company Limited has submitted their response. |
| 25 Mar, 2025 | BSE India | Clarification on Price Movement |
| 25 Mar, 2025 | BSE India | The Exchange has sought clarification from Sun Pharma Advanced Research Company Ltd on March 25, 2025 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited. |
| 25 Mar, 2025 | NSE India | Significant movement in price has been observed in Sun Pharma Advanced Research Company Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. |
| 05 Mar, 2025 | NSE India | Sun Pharma Advanced Research Company Limited has informed the Exchange about Credit Rating- Revision |
| 05 Mar, 2025 | BSE India | Intimation regarding credit rating |
| 12 Feb, 2025 | NSE India | Sun Pharma Advanced Research Company Limited has informed the Exchange about Copy of Newspaper Publication pertaining to financial results of Q3 FY 25 |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 01 Feb, 2025 | 10 Feb, 2025 |
| Quarterly Results | -- | 28 Oct, 2024 | 04 Nov, 2024 |
| Quarterly Results | -- | 30 Jul, 2024 | 05 Aug, 2024 |
| Audited Results | -- | 21 May, 2024 | 24 May, 2024 |
| Quarterly Results | -- | 24 Jan, 2024 | 05 Feb, 2024 |
| Quarterly Results | -- | 30 Oct, 2023 | 06 Nov, 2023 |
| Quarterly Results | -- | 02 Aug, 2023 | 07 Aug, 2023 |
| Audited Results & Others | To consider Fund Raising | 21 May, 2023 | 22 May, 2023 |
| Quarterly Results | -- | 07 Feb, 2023 | 13 Feb, 2023 |
| Quarterly Results | -- | 31 Oct, 2022 | 07 Nov, 2022 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
|---|---|---|---|---|---|
| Promoter Group | 65.67% | 65.67% | 68.22% | 68.1% | 68.46% |
| Foreign Institutions + | 2.23% | 3.3% | 3.48% | 2.51% | 3.06% |
| Domestic Institutions + | 0.64% | 0.81% | 0.93% | 0.55% | 0.01% |
| Government | 0% | 0% | 0% | 0% | 0% |
| Public | 31.46% | 30.22% | 27.37% | 28.84% | 28.47% |
| Others | 0% | 0% | 0% | 0% | 0% |
About Sun Pharma Advanced Research Company
Sun Pharma Advanced Research Company is a Public Limited Listed company incorporated on 01/03/2006 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L73100GJ2006PLC047837 and registration number is 047837. Currently Company is involved in the business activities of Research and experimental development on natural sciences and engineering. Company’s Total Operating Revenue is Rs. 75.55 Cr. and Equity Capital is Rs. 32.45 Cr. for the Year ended 31/03/2024.
Parent Organisation
Not Applicable
Founded
2006
Managing Director
-- --
NSE Symbol
SPARC
Sun Pharma Advanced Research Company Management
| Name | Designation |
|---|---|
| Mr. Dilip S Shanghvi | Chairman & Non-Exe.Director |
| Dr. T Rajamannar | Non Executive Director |
| Dr. Robert J Spiegel | Independent Director |
| Mr. Sudhir V Valia | Non Executive Director |
| Ms. Bhavna Doshi | Independent Director |
| Dr. Ferzaan Engineer | Independent Director |
| Ms. Vidhi Shanghvi | Non Exe.Non Ind.Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Syngene International | ₹29,169.84 | ₹724.65  ₹747.15(-3.01%) | ₹608.000 - ₹960.000 |
| Sun Pharma Advanced Research Company | ₹4,723.09 | ₹145.54 ₹150.00(-2.97%) | ₹109.200 - ₹474.000 |
| Suven Life Sciences | ₹2,807.04 | ₹128.72 ₹131.41(-2.05%) | ₹83.270 - ₹169.000 |
| Vimta Labs | ₹2,055.47 | ₹924.45 ₹1,092.35(-15.37%) | ₹420.000 - ₹1,183.000 |
| Choksi Laboratories | ₹82.82 | ₹118.90 ₹123.40(-3.65%) | ₹46.010 - ₹142.400 |
FAQs on Sun Pharma Advanced Research Company
What is the share price of Sun Pharma Advanced Research Company?
The share price of Sun Pharma Advanced Research Company on 04 Apr, 2025 is ₹ 145.54.
What is 52W high and 52W low share price of Sun Pharma Advanced Research Company?
The highest and lowest 52W share prices of Sun Pharma Advanced Research Company are ₹ 474.000 and ₹ 109.200
What is the market cap of Sun Pharma Advanced Research Company?
The market capitalization of Sun Pharma Advanced Research Company as of 04 Apr, 2025 is ₹ 4,723.09 Crores
What is the P/E ratio of Sun Pharma Advanced Research Company?
The current P/E ratio of Sun Pharma Advanced Research Company as of 04 Apr, 2025 is 61.88
What is the PB ratio of Sun Pharma Advanced Research Company?
The PB ratio of Sun Pharma Advanced Research Company as of 04 Apr, 2025 is 37.51
Top Gainers
₹18.07
₹15.14 (0.19%)
₹66.60
₹57.80 (0.15%)
₹88.74
₹73.95 (0.20%)
₹197.50
₹167.35 (0.18%)
Top Losers
₹307.35
₹368.55 (-0.17%)
₹108.20
₹127.00 (-0.15%)
₹0.54
₹1.03 (-0.48%)
₹2,705.55
₹3,206.90 (-0.16%)
Market Indices
Sensex
₹75,364.69
₹76,295.36 (-0.01%)